World's Best Scientists 2026 revealed!
Jennifer G. Robinson

Jennifer G. Robinson

D-Index & Metrics

Medicine

D-Index
96
Citations
61333
World Ranking
9461
National Ranking
4881

Overview

Jennifer G. Robinson is affiliated with the University of Iowa in the United States. Their research primarily focuses on medicine, with a particular emphasis on economics and econometrics, cardiology and cardiovascular medicine, surgery, public health, environmental and occupational health, and endocrinology, diabetes, and metabolism.

Robinson's work covers several main topics, including lipoproteins and cardiovascular health, health systems, economic evaluations, quality of life, pharmaceutical economics and policy, cardiovascular health and risk factors, diabetes, cardiovascular risks, and lipoproteins, medication adherence and compliance, as well as cardiac health and mental health.

Their recent publications include:

  • Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working Group, 2020, Journal of the American Heart Association
  • Association of Low-Density Lipoprotein Cholesterol Levels with More than 20-Year Risk of Cardiovascular and All-Cause Mortality in the General Population, 2022, Journal of the American Heart Association
  • Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies, 2020, PLoS Medicine
  • Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy, 2021, Circulation Cardiovascular Quality and Outcomes
  • Earlier treatment in adults with high lifetime risk of cardiovascular diseases: What prevention trials are feasible and could change clinical practice? Report of a National Heart, Lung, and Blood Institute (NHLBI) Workshop, 2022, American Journal of Preventive Cardiology

Frequent co-authors working alongside Robinson include Wei Bao, Ann Marie Návar, JoAnn E. Manson, Gang Fang, and Tracy Y. Wang.

Robinson's research has appeared in various publication venues, notably UNC Libraries, Journal of the American Heart Association, Journal of Clinical Lipidology, Journal of the American College of Cardiology, and Circulation, reflecting a broad dissemination within medical and cardiovascular research domains.

Best Publications

  • 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

    Neil J Stone;Jennifer G Robinson;Alice H. Lichtenstein;C Noel Bairey Merz

  • 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

    David C. Goff;Donald M. Lloyd-Jones;Glen Bennett;Sean Coady

  • 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

    David C. Goff;Donald M. Lloyd-Jones;Faha Glen Bennett;Sean Coady

  • Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

    Jennifer G. Robinson;Michel Farnier;Michel Krempf;Jean Bergeron

  • Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association

    Frank M. Sacks;Alice H. Lichtenstein;Jason H.Y. Wu;Lawrence J. Appel

  • The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.

    D I Swerdlow;M V Holmes;K B Kuchenbaecker

  • Loss-of-function mutations in APOC3, triglycerides, and coronary disease

    Jacy Crosby;Gina M. Peloso;Gina M. Peloso;Paul L. Auer;David R. Crosslin

  • HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.

    Daniel I Swerdlow;David Preiss;Karoline B Kuchenbaecker;Michael Holmes

  • Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia

    Anne C. Goldberg;Paul N. Hopkins;Peter P. Toth;Christie M. Ballantyne

  • Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes

    Brian A. Ference;Jennifer G. Robinson;Robert D. Brook;Alberico L. Catapano

  • Noninvasive Pulse Wave Analysis for the Early Detection of Vascular Disease

    Jay N Cohn;Stanley M Finkelstein;Gary McVeigh;Dennis Morgan

  • Optimism, Cynical Hostility, and Incident Coronary Heart Disease and Mortality in the Women’s Health Initiative

    Hilary A. Tindle;Yue-Fang Chang;Lewis H. Kuller;JoAnn E. Manson

  • Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial

    Jennifer G. Robinson;Bettina S. Nedergaard;William J. Rogers;Jonathan Fialkow

  • Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk

    Jennifer G. Robinson;Songfeng Wang;Brian J. Smith;Terry A. Jacobson

  • Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis.

    Jennifer G. Robinson;Brian Smith;Nidhi Maheshwari;Helmut Schrott

  • Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis.

    Eliano P Navarese;Jennifer G Robinson;Mariusz Kowalewski;Michalina Kolodziejczak

  • Cognitive Function in a Randomized Trial of Evolocumab

    Robert P. Giugliano;François Mach;Kenton Zavitz;Christopher Kurtz

  • Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

    M.S. Sabatine;R.P. Giugliano;S.D. Wiviott

  • Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study.

    Dean J. Kereiakes;Jennifer G. Robinson;Christopher P. Cannon;Christelle Lorenzato

  • HMG-COENZYME A REDUCTASE INHIBITION, TYPE 2 DIABETES, AND BODYWEIGHT: EVIDENCE FROM GENETIC ANALYSIS AND RANDOMISED TRIALS

    D Swerdlow;D Preiss;A D Hingorani;N Sattar

Frequent Co-Authors

JoAnn E. Manson
JoAnn E. Manson Harvard Medical School
Robert B. Wallace
Robert B. Wallace University of Iowa
Charles B. Eaton
Charles B. Eaton Brown University
Bruce M. Psaty
Bruce M. Psaty University of Washington
Barbara V. Howard
Barbara V. Howard MedStar Health
Christie M. Ballantyne
Christie M. Ballantyne Baylor College of Medicine
Eric Boerwinkle
Eric Boerwinkle The University of Texas Health Science Center at Houston
Charles Kooperberg
Charles Kooperberg Fred Hutchinson Cancer Research Center
Mark A. Espeland
Mark A. Espeland Wake Forest University
Alexander P. Reiner
Alexander P. Reiner University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare but exploring alternative routes to traditional medical school, a variety of online degrees can open rewarding career pathways. Programs like the shortest online pmhnp programs allow students to quickly gain advanced skills as Psychiatric Mental Health Nurse Practitioners, providing essential mental health care in clinical or community settings.

Students looking for roles on the administrative side of healthcare can consider an online healthcare administration degree. These degrees prepare graduates to handle leadership, operations, and organizational challenges in hospitals and clinics.

For those seeking more advanced administrative qualifications at an accessible price, the cheapest mha online programs deliver management and policy expertise while offering significant savings on tuition.

Finally, nurses aspiring to the highest level of practice and leadership may pursue the best online bsn to dnp programs. These doctorates equip graduates for top-tier clinical, policy, and academic roles to advance patient care and healthcare systems.

Best Scientists Citing Jennifer G. Robinson

Trending Scientists

Recently Published Articles